tiprankstipranks
Trending News
More News >
Coherus Biosciences (CHRS)
NASDAQ:CHRS
US Market
Advertisement

Coherus Biosciences (CHRS) Technical Analysis

Compare
1,613 Followers

Technical Sentiment

Overall Consensus
Buy
15Bullish
3Neutral
4Bearish
Technical Analysis Consensus
Sell
3Bullish
3Neutral
4Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Coherus Biosciences’s (CHRS) Moving Averages Convergence Divergence (MACD) indicator is 0.08, suggesting Coherus Biosciences is a Sell.
Coherus Biosciences’s (CHRS) 20-Day exponential moving average is 1.12, while Coherus Biosciences’s (CHRS) share price is $1.31, making it a Buy.
Coherus Biosciences’s (CHRS) 50-Day exponential moving average is 1.01, while Coherus Biosciences’s (CHRS) share price is $1.31, making it a Buy.

Coherus Biosciences (CHRS) Pivot Points

Sep 06, 2025, 06:38 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.11
1.15
1.20
1.24
1.29
1.33
1.38
Fibonacci
1.15
1.18
1.20
1.24
1.27
1.29
1.33
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Coherus Biosciences (CHRS) Moving Averages

Sep 06, 2025, 06:38 PM
Period
Simple
Exponential
MA5
1.22Buy
1.24Buy
MA10
1.19Buy
1.19Buy
MA20
1.08Buy
1.12Buy
MA50
0.96Buy
1.01Buy
MA100
0.92Buy
0.97Buy
MA200
1.06Buy
1.03Buy
Coherus Biosciences’s (CHRS) 10-Day exponential moving average is 1.19, while Coherus Biosciences’s (CHRS) share price is $1.31, making it a Buy.
Coherus Biosciences’s (CHRS) 100-Day exponential moving average is 0.97, while Coherus Biosciences’s (CHRS) share price is $1.31, making it a Buy.
Coherus Biosciences’s (CHRS) stock price is $1.31 and Coherus Biosciences’s (CHRS) 50-day simple moving average is 0.96, creating a Buy signal.
Coherus Biosciences’s (CHRS) stock price is $1.31 and Coherus Biosciences’s (CHRS) 100-day simple moving average is 0.92, creating a Buy signal.
Coherus Biosciences’s (CHRS) stock price is $1.31 and Coherus Biosciences’s (CHRS) 200-day simple moving average is 1.06, creating a Buy signal.

Coherus Biosciences (CHRS) Technical Indicators

Sep 06, 2025, 06:38 PM
Name
Value
Implied Action
RSI (14)
72.27
Sell
STOCH (9,6)
77.86
Neutral
STOCHRSI (14)
84.89
Sell
MACD (12,26)
0.08
Sell
ADX (14)
32.08
Neutral
Williams %R
-21.62
Buy
CCI (14)
156.84
Sell
ATR (14)
0.08
-
Ultimate Oscillator
55.34
Neutral
ROC
28.43
Buy
Coherus Biosciences’s (CHRS) Relative Strength Index (RSI) is 72.27, creating a Sell signal.
Coherus Biosciences’s (CHRS) Trend Strength Indicator (ADX) is 32.08, creating a Neutral signal.
Coherus Biosciences’s (CHRS) Commodity Channel Index (CCI) is 156.84, creating a Sell signal.
Coherus Biosciences’s (CHRS) Price Rate of Change (ROC) is 28.43, creating a Buy signal.

FAQ

Is CHRS a Buy, Hold, or Sell?
Based on CHRS’s technical indicators, CHRS is a Buy.
    What is CHRS’s RSI (14)?
    CHRS’s RSI (14) is 72.27, which suggests CHRS is a Sell.
      What is CHRS’s MACD?
      CHRS’s MACD is 0.08, which suggests CHRS is a Sell.
        What is CHRS’s 5-day moving average?
        CHRS’s 5-day moving average is 1.22, which suggests CHRS is a Buy.
          What is CHRS’s 20-day moving average?
          CHRS 20-day moving average is 1.08, which suggests CHRS is a Buy.
            What is CHRS’s 50-day moving average?
            CHRS’s 50-day moving average is 0.96, which suggests CHRS is a Buy.
              What is CHRS’s 200-day moving average?
              CHRS’s 200-day moving average is 1.06, which suggests CHRS is a Buy.
                What is CHRS’s Williams % R (14)?
                CHRS’s Williams % R (14) is -21.62, which suggests CHRS is a Buy.
                  What is CHRS’s CCI (14)?
                  CHRS’s CCI (14) is 156.84, which suggests CHRS is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis